Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 0.31 USD -1.59% Market Closed
Market Cap: 23.4m USD
Have any thoughts about
Oncology Institute Inc?
Write Note

Intrinsic Value

TOI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one TOI stock under the Base Case scenario is 3.38 USD. Compared to the current market price of 0.31 USD, Oncology Institute Inc is Undervalued by 91%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TOI Intrinsic Value
3.38 USD
Undervaluation 91%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Oncology Institute Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TOI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TOI?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Oncology Institute Inc

Provide an overview of the primary business activities
of Oncology Institute Inc.

What unique competitive advantages
does Oncology Institute Inc hold over its rivals?

What risks and challenges
does Oncology Institute Inc face in the near future?

Has there been any significant insider trading activity
in Oncology Institute Inc recently?

Summarize the latest earnings call
of Oncology Institute Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Oncology Institute Inc.

Provide P/S
for Oncology Institute Inc.

Provide P/E
for Oncology Institute Inc.

Provide P/OCF
for Oncology Institute Inc.

Provide P/FCFE
for Oncology Institute Inc.

Provide P/B
for Oncology Institute Inc.

Provide EV/S
for Oncology Institute Inc.

Provide EV/GP
for Oncology Institute Inc.

Provide EV/EBITDA
for Oncology Institute Inc.

Provide EV/EBIT
for Oncology Institute Inc.

Provide EV/OCF
for Oncology Institute Inc.

Provide EV/FCFF
for Oncology Institute Inc.

Provide EV/IC
for Oncology Institute Inc.

Show me price targets
for Oncology Institute Inc made by professional analysts.

What are the Revenue projections
for Oncology Institute Inc?

How accurate were the past Revenue estimates
for Oncology Institute Inc?

What are the Net Income projections
for Oncology Institute Inc?

How accurate were the past Net Income estimates
for Oncology Institute Inc?

What are the EPS projections
for Oncology Institute Inc?

How accurate were the past EPS estimates
for Oncology Institute Inc?

What are the EBIT projections
for Oncology Institute Inc?

How accurate were the past EBIT estimates
for Oncology Institute Inc?

Compare the revenue forecasts
for Oncology Institute Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Oncology Institute Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Oncology Institute Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Oncology Institute Inc compared to its peers.

Compare the P/E ratios
of Oncology Institute Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Oncology Institute Inc with its peers.

Analyze the financial leverage
of Oncology Institute Inc compared to its main competitors.

Show all profitability ratios
for Oncology Institute Inc.

Provide ROE
for Oncology Institute Inc.

Provide ROA
for Oncology Institute Inc.

Provide ROIC
for Oncology Institute Inc.

Provide ROCE
for Oncology Institute Inc.

Provide Gross Margin
for Oncology Institute Inc.

Provide Operating Margin
for Oncology Institute Inc.

Provide Net Margin
for Oncology Institute Inc.

Provide FCF Margin
for Oncology Institute Inc.

Show all solvency ratios
for Oncology Institute Inc.

Provide D/E Ratio
for Oncology Institute Inc.

Provide D/A Ratio
for Oncology Institute Inc.

Provide Interest Coverage Ratio
for Oncology Institute Inc.

Provide Altman Z-Score Ratio
for Oncology Institute Inc.

Provide Quick Ratio
for Oncology Institute Inc.

Provide Current Ratio
for Oncology Institute Inc.

Provide Cash Ratio
for Oncology Institute Inc.

What is the historical Revenue growth
over the last 5 years for Oncology Institute Inc?

What is the historical Net Income growth
over the last 5 years for Oncology Institute Inc?

What is the current Free Cash Flow
of Oncology Institute Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Oncology Institute Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oncology Institute Inc

Current Assets 116.2m
Cash & Short-Term Investments 46.4m
Receivables 54.4m
Other Current Assets 15.5m
Non-Current Assets 63.4m
PP&E 39.2m
Intangibles 23.6m
Other Non-Current Assets 582k
Current Liabilities 35.1m
Accounts Payable 15.8m
Accrued Liabilities 13.1m
Other Current Liabilities 6.2m
Non-Current Liabilities 115.3m
Long-Term Debt 90m
Other Non-Current Liabilities 25.3m
Efficiency

Earnings Waterfall
Oncology Institute Inc

Revenue
361.1m USD
Cost of Revenue
-305.7m USD
Gross Profit
55.4m USD
Operating Expenses
-118.9m USD
Operating Income
-63.6m USD
Other Expenses
5m USD
Net Income
-58.5m USD

Free Cash Flow Analysis
Oncology Institute Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 2024, The Oncology Institute reported a revenue increase of 22.9% year-over-year, reaching $98.6 million, largely driven by their new California pharmacy. However, margins were pressured due to rising DIR fees, leading to a gross profit of $13 million. The company updated its guidance for full-year gross profit to a range of $62 million to $69 million and adjusted EBITDA to between negative $21 million and negative $28 million. Encouragingly, new capitation contracts are expected to contribute over $41 million in revenue, enhancing profitability potential as they go live in Q3.

What is Earnings Call?
Fundamental Scores

TOI Profitability Score
Profitability Due Diligence

Oncology Institute Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Declining ROIC
19/100
Profitability
Score

Oncology Institute Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

TOI Solvency Score
Solvency Due Diligence

Oncology Institute Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
High D/E
30/100
Solvency
Score

Oncology Institute Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TOI Price Targets Summary
Oncology Institute Inc

There are no price targets for TOI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TOI?

Click here to dive deeper.

Dividends

Oncology Institute Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TOI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TOI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Oncology Institute Inc Logo
Oncology Institute Inc

Country

United States of America

Industry

Health Care

Market Cap

23.4m USD

Dividend Yield

0%

Description

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

Contact

CALIFORNIA
Cerritos
18000 Studebaker Rd, Suite 800
+15627353226.0
theoncologyinstitute.com

IPO

2020-03-13

Employees

3

Officers

See Also

Discover More
What is the Intrinsic Value of one TOI stock?

The intrinsic value of one TOI stock under the Base Case scenario is 3.38 USD.

Is TOI stock undervalued or overvalued?

Compared to the current market price of 0.31 USD, Oncology Institute Inc is Undervalued by 91%.

Back to Top